WELL Health Technologies Corp.

TSX:WELL.TO

Medical - Care Facilities

Healthcare
$3.70 +0.34%

+$0.02 today

Market cap
$947.00M
Beta
1.33
P/E (TTM)
41.6
EPS (TTM)
$0.11
52W Low $3.58High $6.08

Volume 2.80M

Average 1.62M

WELL.TO Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

WELL Health Technologies Corp.TSX: WELL.TO

Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026

Capital expenditures growth accelerates

Q1 FY2026 capital expenditures of CA$10.22M (cash outflow) rose 87.7% year over year, ahead of the +62.7% change in trailing-twelve-month capital expenditures. Sequentially, it rose 20.5% from the prior quarter. Over 3 fiscal years it compounded at +63.3% a year.

Context

  • Capital expenditures amounted to 2.0% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Capital expenditures grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +87.7% holds above the trailing-twelve-month pace of +62.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$10.22M+20.5% QoQ
Last fiscal yearDec 2025
-CA$27.87M+71.8% YoY
LTMMar 2026
-CA$32.64M+62.7% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+87.7%——
1 year+71.8%——
3-year CAGR+63.3%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

CAD · from the cash flow

Latest · FY2025
(27.87M) CAD
Year-over-year change
-71.8%

Capital Expenditures vs competitors

How WELL.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +62.7% is the 2nd highest of 5, against a peer median of -17.3%.
  • Capital expenditures amounts to 2.2% of revenue for WELL.TO, versus a peer median of 6.2%.
WELL.TO Competitors
Capital Expenditures for WELL.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$118.65M CAD-28.6%+35.2%10.7%
EXE.TOExtendicare Inc.LTM Jun 2026CA$90.4M CAD+72.2%+0.1%4.6%
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$32.64M CAD+62.7%+63.3%2.2%
CRON.TOCronos Group Inc.LTM Mar 2026$12.43M USD-53.1%+73.2%7.8%
DR.TOMedical Facilities CorporationLTM Mar 2026$5.72M USD-6.0%-9.6%1.9%
Peer median (excluding WELL.TO) —-17.3%+17.6%6.2%

Competitors are the stored peer set for WELL.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(30.9M)18.68M82K29.1M4.46M
Depreciation & Amortization38.22M55.2M60.77M72.31M93.76M
Deferred Income Tax1.04M(978K)(10.42M)(31.62M)(16.38M)
Stock-Based Compensation21.01M24.48M26.16M15.27M22.69M
Change in Working Capital(11.2M)(6.06M)(10.25M)6.67M(36.7M)
Accounts Receivables(13.27M)(9.37M)(2.49M)(80.25M)47.3M
Inventory876K(577K)190K(1.51M)231K
Accounts Payables1.6M10.55M(9.21M)36.42M(20.12M)
Other Working Capital(399K)(6.67M)1.26M52.02M(64.12M)
Other Non-Cash Items4.1M(14.78M)95K(82.21M)47.96M
Operating Cash Flow22.27M76.55M66.44M9.52M115.79M
Capital Expenditures(2.68M)(6.4M)(25.38M)(16.23M)(27.87M)
Acquisitions (Net)(421.76M)(31.13M)(72.78M)(37.27M)(80.51M)
Purchases of Investments(3.12M)(16.51M)0(73K)0
Sales of Investments3.12M16.51M11.56M2.39M15.1M
Other Investing Activities(75.33M)(396K)(19.82M)(9.05M)(18.47M)
Investing Cash Flow(499.78M)(37.93M)(106.42M)(60.23M)(111.74M)
Debt Repayment171.07M(58.75M)38.77M(49.34M)157.6M
Common Stock Issued302.5M34.51M810K3.22M445K
Common Stock Repurchased0(243K)0(1.66M)(1.83M)
Dividends Paid00000
Other Financing Activities(21.04M)6.15M(28.14M)136.85M(155.28M)
Financing Cash Flow452.53M(52.85M)10.63M133.5M941K
Effect of Forex Changes9K1.22M(532K)4.75M(2.91M)
Net Change in Cash(24.97M)(13.01M)(5.49M)88.25M2.09M
Free Cash Flow19.59M70.14M37.2M(6.7M)87.92M

WELL Health Technologies Corp.

TSX:WELL.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.